Search Results - "Pavy, M D"

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study by Muss, H B, Case, L D, Atkins, J N, Bearden, 3rd, J D, Cooper, M R, Cruz, J M, Jackson, Jr, D V, O'Rourke, M A, Pavy, M D, Powell, B L

“…To determine in a prospective randomized trial whether high-dose orally administered medroxy-progesterone acetate (MPA) was superior to tamoxifen in patients…”
Get more information

Comparison of patient-controlled and nurse-controlled antiemetic therapy in patients receiving chemotherapy by Edwards, J N, Herman, J A, Wallace, B K, Pavy, M D, Harrison-Pavy, J

“…The purpose of this quasi-experimental pilot study was to compare the effect of patient-controlled (PCAE) and nurse administered (NCAE) antiemetic therapy for…”
Get more information

Vinblastine infusion in non-Hodgkin's lymphomas: lack of total cross-resistance with vincristine by Jackson, Jr, D V, Spurr, C L, Caponera, M E, White, D R, Muss, H B, Pavy, M D, Sartiano, G P, Zekan, P J, Hire, E A

“…Historically, vinblastine given by intravenous bolus injection has not been an effective treatment for non-Hodgkin's lymphomas; vincristine has displayed…”
Get more information

Moderate-dose vincristine infusion in refractory breast cancer by Jackson, D V, White, D R, Spurr, C L, Hire, E A, Pavy, M D, Robertson, M, Legos, H C, McMahan, R A

“…Continuous infusion of vincristine at the maximally tolerated infusion dosage of 0.5 mg/m2/day for 5 days has been investigated in 15 patients with refractory…”
Get more information

Vincristine infusion in refractory gynecologic malignancies by Jackson, Jr, D V, Jobson, V W, Homesley, H D, Welander, C, Hire, E A, Pavy, M D, Votaw, M L, Richards, 2nd, F, Muss, H B

“…Prolonged intravenous infusion of vincristine was evaluated in 26 patients with advanced, refractory gynecologic malignancies. Most patients (88%) had…”
Get more information

Paraprotein-induced hyperviscosity. A reversible cause of stroke by Pavy, M D, Murphy, P L, Virella, G

“…Although the occurrence of the hyperviscosity syndrome with IgG plasma cell leukemia is unusual, it should be considered in the evaluation of patients with…”
Get more information

Hemolytic-uremic syndrome associated with mitomycin therapy by Pavy, M D, Wiley, E L, Abeloff, M D

Get more information

Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation by Rhodes, D F, Lee, W M, Wingard, J R, Pavy, M D, Santos, G W, Shaw, B W, Wood, R P, Sorrell, M F, Markin, R S

“…Chronic graft-vs.-host disease occurs in 30%-50% of long-term survivors of allogeneic bone marrow grafts, and may eventuate in cirrhosis. In this study, a…”
Get more information

Acute leukemia following intensive therapy for small-cell carcinoma of the lung by Markman, M, Pavy, M D, Abeloff, M D

Get more information

Possible recurrence of Legionnaires' disease by Pavy, M D, Johnson, A H

Get more information

Colchicine for Post-Operative Pericardial Effusion by Meurin, Philippe, MD, Lelay-Kubas, Sophie, MD, Pierre, Bernard, MD, Pereira, Helena, MSc, Pavy, Bruno, MD, Iliou, Marie Christine, MD, Bussiere, Jean Louis, MD, Weber, Helene, MD, Beugin, Jean Pierre, MD, Farrokhi, Titi, MD, Bellemain-Appaix, Anne, MD, Briota, Laura, MD, Tabet, Jean-Yves, MD

“…[...]197 patients (172 were needed by assuming that the spontaneous decrease in mean pericardial effusion grade would be 0.6 grade [5]) were enrolled 16.2 ±…”
Get full text

Gynecomastia in men following antineoplastic therapy by Trump, D L, Pavy, M D, Staal, S

“…Six men had painful gynecomastia develop during or following the administration of cytotoxic chemotherapy. Alternative causes of gynecomastia were not…”
Get more information